The Estrogen Patch Shortage: What Denver Women Can Do About It

If your pharmacy cannot fill your estradiol patch, you are not imagining it, and you are not out of options. The FDA has acknowledged that women are having trouble getting their usual patches, and at the same time it has not declared a formal shortage. Both things are true right now, which is why the situation feels so confusing.

Is there actually an estrogen patch shortage?

Not an official one. On September 3, 2026, the FDA published an update saying it "is aware of reports of patients having difficulty readily accessing their usual estradiol transdermal patches due to increased demand" and that it "is working with all six manufacturers to increase supply." In that same update the agency said estradiol transdermal patches "remain available," while noting that which products or brands you can get may vary by pharmacy and by location. The FDA also said the supply of FDA-approved estradiol patches has nearly doubled over the past year.

A declared shortage is a specific thing. The FDA keeps a formal drug shortage list, and as of this writing estradiol patches are not on it.

So why does everyone call it a shortage? Because pharmacists do. The American Society of Health-System Pharmacists keeps its own shortage list, and it has carried estradiol transdermal patches since January 2026. In July 2026 a group of lawmakers wrote to the FDA asking the agency to add the patches to the federal list. One word is doing two jobs: describing what is happening at the pharmacy counter, and naming a regulatory designation with its own criteria.

The practical translation is short. Your usual brand may be hard to find this month. Estradiol as a medication is not going away.

Why did demand go up?

A label change is part of it. In November 2025 the FDA asked the makers of menopausal hormone therapy to remove boxed warning language about cardiovascular disease, breast cancer, and probable dementia, and to drop the old instruction to use the lowest dose for the shortest time. The FDA kept the boxed warning about endometrial cancer on systemic estrogen-alone products, which matters for women who still have a uterus.

More women started the conversation after that. Epic Research, which analyzes data from a large health records database, reported that hormone therapy prescribing among women ages 50 to 65 rose about 86 percent from 2021 through the end of 2025. Manufacturing capacity did not move that fast.

What are the alternatives to the estradiol patch?

The patch is one delivery form. It is not the only one, and the alternatives are real medicine, not consolation prizes.

Systemic estradiol, the kind prescribed for hot flashes and night sweats, is FDA-approved as a transdermal patch, a topical gel, a transdermal spray, an oral pill, and a systemic vaginal ring. Some of these products are also approved to help prevent postmenopausal osteoporosis. For a woman who still has a uterus, estrogen is generally prescribed together with a progestogen to protect the uterine lining, and some combination products deliver both in one patch or one pill.

Low-dose vaginal estrogen is a different category. Vaginal creams, tablets, inserts, and the low-dose ring are FDA-approved for the vaginal and urinary symptoms of menopause: dryness, irritation, and painful sex. They are not approved to treat hot flashes and night sweats, and they do not replace systemic therapy.

Changing forms is not a swap you make at the pharmacy counter. Absorption differs from one form to the next, so the dose is not a straight conversion, and the routine differs too: a gel or spray goes onto clean dry skin and needs time to absorb, a patch is changed on a schedule. That is a prescriber's call, and it usually comes with a short follow-up to see how you feel once you have settled onto the new form.

How does compounded hormone therapy fit in?

Compounding is how a pharmacy prepares a medication to a prescriber's specification for one individual patient.

A 503A compounding pharmacy makes a preparation for a single patient against a prescription, under its state board of pharmacy license and FDA oversight. A 503B outsourcing facility registers with the FDA and produces under Current Good Manufacturing Practice requirements. Both are a regular, regulated part of medical practice.

What compounding gives a provider is range. If the strength you do best on is not one that any manufactured product is made in, or a preparation without a particular adhesive or preservative would suit you better, a compounding pharmacy can make that. Your provider writes the prescription, sets the dose, and follows how you respond over time. The pharmacy fills it. The clinical management stays with your clinician. Estradiol itself is an FDA-approved active ingredient.

For a woman in Denver who has spent three weeks calling pharmacies, that range is the useful part: a provider who prescribes across the FDA-approved forms and through a licensed compounding pharmacy has more ways to keep you on steady treatment than a single brand of patch. Here at Redbud, we do prescribe hormone therapy using 503A and 503B compounding pharmacies, meaning this is something we can help you with if your current prescriber does not do the same.

What should you do if your pharmacy cannot fill your patch?

Call your prescriber's office as soon as you know there is a problem, ideally before your last box runs out. Stopping quietly and waiting it out is the option that tends to go worst, because your symptoms come back while nobody on your care team knows you are without medication.

Ask your pharmacy whether a different manufacturer's patch or a different dose is in stock, and whether another location can transfer one. Availability is uneven right now, pharmacy by pharmacy, and Denver is no exception.

Then let your prescriber decide the next move. That may be a different patch, a different form, or a compounded preparation. If you are tempted to stretch a box by wearing a patch longer than you were told to, call first instead. A five minute phone call is usually all it takes to get a new prescription sent somewhere that has stock.

What to expect at Redbud

Hormone care at Redbud starts with a conversation, not a protocol. You will be asked about your symptoms, your history, what you have already tried, and what has and has not worked. Lab work and follow-up are part of how treatment is managed, so you are not left to guess whether a new form is working.

If you are already on hormone therapy and the supply problem has interrupted it, bring the box, the dose, and the name of your prescriber. Continuity is the goal. If hormone therapy is not a good fit for you, you will hear that plainly.

You can read more on our BHRT page, meet the providers who would be sitting across from you, and find general questions answered on our FAQ page.

If your patch has been hard to fill and you want a plan instead of another phone tree, book a consultation at our Denver office.

Medical disclaimer: This article is for general education and is not medical advice. Regulatory and supply status is current as of September 2026 and can change. FDA-approved menopausal hormone therapy is approved to treat specific menopause symptoms, and some products are also approved to help prevent postmenopausal osteoporosis. It is not approved to prevent heart disease, dementia, or aging. A compounded preparation is made by a licensed compounding pharmacy for an individual patient against a prescription, and it is not an FDA-approved product. Hormone therapy is not right for everyone, and individual results vary. Please talk with a licensed medical provider about your own history before starting, changing, or stopping any hormone therapy.